10 citations
,
January 2017 in “The World Allergy Organization journal” Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.
1 citations
,
June 2025 in “Pharmacia” Botulinum toxin is effective for medical and cosmetic uses but requires careful handling to avoid serious side effects.
3 citations
,
February 2023 in “BMJ Case Reports” A woman in her 30s with a history of trichotillomania (TTM) and chronic migraines showed significant improvement in TTM symptoms and hair regrowth after receiving off-label onabotulinumtoxinA (OBTA) treatment, initially intended for her migraines. Despite previous unsuccessful treatments with behavioral therapy and SSRIs, OBTA injections (45 units total) in the scalp led to marked improvement in TTM symptoms and hair regrowth as early as 12 weeks post-treatment, with sustained effects and further hair regrowth observed after one year and four treatment cycles.
219 citations
,
January 2005 in “Plastic & Reconstructive Surgery” Surgical treatment can significantly reduce or eliminate migraine symptoms.
April 2023 in “Journal of Investigative Dermatology” CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.